Dan Kaufman

Dr. Kaufman is a Professor of Medicine and vice chief of the Division of Regenerative Medicine. Studies in the Kaufman lab have pioneered the development of human iPSC-derived natural killer (NK) cells to kill diverse types of human cancer cells. This work has been translated to clinical trials. New work aims to develop direct in vivo engineering of immune cells as a novel cancer treatment. He is also co-Director of the Sanford Advanced Therapy Center and Scientific/Medical Director of the UCSD Advanced Cell Therapy Laboratory (ACTL) that provides GMP cell manufacturing to translate new cell-based therapies to clinical trials. He is also clinical director of the Cell and Regenerative Medicine service.